Kangfu Ling Jiaonang (康妇灵胶囊)康妇灵胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

杠板归是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:杠板归Gangban Gui、苦参Ku Shen、黄柏等Huangbai Deng。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:杠板归-60749275成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 康妇灵胶囊) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 杠板归Gangban Gui, 苦参Ku Shen, 黄柏等Huangbai Deng.

Explore other medicines containing the same ingredient: 杠板归 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 康妇灵胶囊Recorded Chinese name: 康妇灵胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 0.4g*36粒0.4 g × 36 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 贵州百灵企业集团和仁堂药业有限公司Chinese legal name: 贵州百灵企业集团和仁堂药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20025767

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20025767

Manufacturer

Chinese legal name: 贵州百灵企业集团和仁堂药业有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

0.4 g × 36 capsules

中文说明书原文Original Chinese source label

批准文号

国药准字Z20025767

生产企业

贵州百灵企业集团和仁堂药业有限公司(国产)

功能主治

清热燥湿,活血化瘀,调经止带。用于湿热下注所致的带下量多,月经量少、后错,痛经。

用法用量

口服,一次3粒,一日3次。

不良反应

尚不明确

禁忌

孕妇禁用。

注意事项

1? 忌食辛辣、生冷、油腻食物。
2? 患有其他疾病者,应在医师指导下服用。
3? 带下清稀者不宜选用。带下伴阴痒或有赤带者应去医院就诊。
4? 伴有尿频、尿急、尿痛者,应去医院就诊。
5? 平素月经正常,突然出现月经量少,或月经错后,或阴道不规则出血应去医院就诊。
6? 服药2周症状无缓解,应去医院就诊。
7? 对本品过敏者禁用,过敏体质者慎用。
8? 本品性状发生改变时禁止使用。
9? 请将本品放在儿童不能接触的地方。
10? 如正在使用其他药品,使用本品前请咨询医师或药师。

贮藏

密封。

规格

0.4g*36粒

证据Evidence

  • 批准文号: 国药准字Z20025767
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.